| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $20K | — | -81.6% |
| Cost of Revenue | $40K | — | -12.3% |
| Gross Profit | -$20K | — | -130.1% |
| R&D Expense | $1.5M | — | +184.6% |
| SG&A Expense | $3.0M | — | +1077.1% |
| Operating Income | -$4.5M | — | -533.2% |
| Pre-tax Income | -$4.5M | — | -542.5% |
| Income Tax | $0 | — | — |
| Net Income | -$4.5M | — | -542.5% |
| EPS (Basic) | -$0.28 | — | -12.0% |
| EPS (Diluted) | -$0.28 | — | -12.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $23.5M | +152.8% | — |
| Current Assets | $24.3M | +158.2% | — |
| Total Assets | $24.9M | +141.2% | — |
| Current Liabilities | $1.3M | +13.6% | — |
| Total Liabilities | $1.4M | +11.3% | — |
| Stockholders' Equity | $23.5M | +336.6% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$4.3M | — | -527.3% |
| Capital Expenditures | $124K | — | — |
| Investing Cash Flow | -$124K | — | — |
| Financing Cash Flow | $18.6M | — | — |
| Free Cash Flow | -$4.4M | — | — |
| +954.5% |